VANCOUVER, BC, August 9, 2024 – WAT Medical Enterprise Ltd. is proud to announce its first donation to The Ehlers-Danlos Society, a global organization dedicated to advancing and accelerating research and education in Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD).
WAT Medical, a leading company in healthcare technology, made a generous contribution to The Ehlers-Danlos Society, including a monetary donation and a selection of their advanced medical products. This donation underscores WAT Medical’s commitment to supporting research and improving the quality of life for individuals affected by EDS and HSD.
The Ehlers-Danlos Society is renowned for its dedication to developing effective and equitable therapies for EDS and HSD and working collaboratively to enhance the lives of those affected by these conditions. WAT Medical's contribution will aid in advancing the Society's mission, supporting vital research, and providing educational resources to the community.
WAT Medical Enterprise is known for developing precise, wearable, and smart medical technologies. With a motivated team leading the field of medical research and development, WAT Medical provides efficient and personalized medical services to individuals worldwide. Their innovative products are designed to address various medical conditions, enhancing the overall well-being of users.
EmeTerm, one of WAT Medical’s flagship products, is a wearable physiotherapy device designed to treat nausea and vomiting. It is effective for conditions such as carsickness, seasickness, pregnancy-related vomiting, airsickness, chemotherapy, and postoperative vomiting. Since 2018, WAT Medical has received the MDSAP certificate issued by BSI, ensuring that the safety and quality of their medical devices exceed the requirements set by the ISO13485 standard. The product is certified by FDA, CE, Health Canada, TGA, and Israel, and has been sold in more than 30 countries, including through cruise channels in the U.S.-Caribbean region.
WAT Medical is making a tangible impact on the lives of those in need by supporting charitable organizations such as The Ehlers-Danlos Society. This initiative exemplifies WAT Medical’s commitment to social responsibility.
WAT Medical will continue to research and develop wearable devices in the field of personal health and remains steadfast in its commitment to social responsibility, consistently providing support to communities and institutions in need.
Reference: